Cargando…
Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer: A meta-analysis
BACKGROUND: Inconsistent findings have been reported regarding the association of C-reactive protein to albumin ratio (CAR) with survival outcome in patients with pancreatic cancer. We conducted the current meta-analysis to assess the prognostic utility of elevated baseline CAR in predicting overall...
Autores principales: | Zang, Ye, Fan, Yu, Gao, Zhenjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306286/ https://www.ncbi.nlm.nih.gov/pubmed/32502031 http://dx.doi.org/10.1097/MD.0000000000020595 |
Ejemplares similares
-
C-reactive protein/albumin ratio is a prognostic indicator in Asians with pancreatic cancers: A meta-analysis
por: Fu, Yan-Jun, et al.
Publicado: (2019) -
Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients
por: Hang, Junjie, et al.
Publicado: (2017) -
Clinical impact of pretreatment albumin–globulin ratio in patients with colorectal cancer: A meta-analysis
por: Ma, Jian-Ying, et al.
Publicado: (2022) -
Pretreatment Neutrophil–Lymphocyte Ratio: An Independent Predictor of Survival in Patients With Hepatocellular Carcinoma
por: Gao, Fangyuan, et al.
Publicado: (2015) -
Preoperative C-reactive protein-to-albumin ratio as a prognostic factor in biliary tract cancer: A systematic review and meta-analysis
por: Utsumi, Masashi, et al.
Publicado: (2023)